Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP Block vs Local Infiltration for Pain in Gynecologic Surgery
NCT04037878Completed
- Sponsor
- Aga Khan University
- Start
- Nov 2017
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of bupivacaine hydrochloride 0.75% injection in pain (3 arms), sponsored by Aga Khan University. Primary endpoint: Total consumption of tramadol. Started Nov 2017; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
pain
Beyond the preview
Go deeper on NCT04037878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04037878.